Vedanta BioSciencies
Edit

Vedanta BioSciencies

https://www.vedantabio.com/
Last activity: 25.04.2023
Categories: HumanFoodTechProductFinTechDevelopment
Vedanta BioSciences designs medicines based on consortia of human commensal bacteria to treat disease, using insights from microbial ecology, mucosal immunology, and human interventional studies.
Website visits
6.3K /mo.
Mentions
40
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $273.9M
Founded date: 2010

Investors 4

Funding Rounds 6

DateSeriesAmountInvestors
25.04.2023-$106.5M-
21.07.2021Series D$68M-
05.12.2019Grant$5.8M-
23.09.2019Series C$16.6M-
01.01.2019Series C$27M-
06.06.2016-$50M-

Mentions in press and media 40

DateTitleDescriptionSource
25.04.2023Vedanta Biosciences Announces $106.5 Million Financing to Ad...Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral th...seventure....
25.04.2023Vedanta Biosciences Raises $106.5M in FundingVedanta Biosciences, a Cambridge, MA-based clinical-stage company that is developing a potential new...finsmes.co...
05.10.2021Vedanta Announces Positive Topline Phase 2 Data for VE303 in...Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral th...marketscre...
05.10.2021Vedanta Announces Positive Topline Phase 2 Data for VE303 in...Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral th...seventure....
22.07.2021Vedanta picks up $68M Series DVedanta Biosciences has raised $68 million in a round led by affiliates of Magnetar Capital. Based i...pitchbook....
21.07.2021Vedanta Biosciences Raises $68M in Series D FinancingVedanta Biosciences, Inc., a Cambridge, Mass.-based clinical-stage microbiome company developing a n...finsmes.co...
21.07.2021Vedanta Biosciences Completes $68M Series D CAMBRIDGE, MA, Vedanta Biosciences, a clinical-stage microbiome company, has raised a $68M Series ...vcnewsdail...
21.07.2021Vedanta raises $68M, reveals setback to Bristol Myers allian...Vedanta Biosciences has raised $68 million to take a microbiome candidate into phase 3. The biotech ...fiercebiot...
12.01.2021PureTech Founded Entity Vedanta Biosciences Announces $25 Mi...Michael Vincent, M.D., Ph.D., Chief Scientific Officer, Inflammation & Immunology Research Unit ...aithority....
30.12.2020Promoters of Vedanta raises $1.4 billion to retire debt, say...Promoters of Vedanta Ltd have pledged their holding in the company to raise $1.4 billion, mostly for...business-s...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In